Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 114401-114450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT02543905
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
N/ARecruiting
1,600 participants
Started: Mar 9, 2015 · Completed: Dec 31, 2026
4 conditions5 sponsors1 location
NCT02361320
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
NARecruiting
259 participants
Started: Mar 9, 2015 · Completed: Jun 27, 2026
1 condition2 sponsors1 location
NCT02387905
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
PHASE2Active, not recruiting
87 participants
Started: Mar 9, 2015 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT02381886
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
PHASE1Active, not recruiting
166 participants
Started: Mar 6, 2015 · Completed: Feb 3, 2026
1 condition1 sponsor16 locations
NCT02386800
CINC424A2X01B Rollover Protocol
PHASE4Active, not recruiting
279 participants
Started: Mar 5, 2015 · Completed: Sep 16, 2027
5 conditions1 sponsor98 locations
NCT02434393
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
N/ARecruiting
120 participants
Started: Mar 4, 2015 · Completed: May 31, 2027
2 conditions4 sponsors2 locations
NCT04792463
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
N/ARecruiting
500 participants
Started: Mar 3, 2015 · Completed: Jul 1, 2026
8 conditions1 sponsor1 location
NCT02389517
Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant
PHASE2Active, not recruiting
42 participants
Started: Mar 2, 2015 · Completed: Mar 31, 2027
2 conditions3 sponsors1 location
NCT02213926
An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma
PHASE2Active, not recruiting
124 participants
Started: Mar 2, 2015 · Completed: Sep 6, 2026
1 condition1 sponsor58 locations
NCT02453542
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
N/ARecruiting
20 participants
Started: Mar 1, 2015 · Completed: Aug 31, 2030
1 condition1 sponsor1 location
NCT02270567
RegisterNET - A Registry for Neuroendocrine Tumors in the USA
N/AEnrolling by invitation
400 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT02287311
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
PHASE1Active, not recruiting
38 participants
Started: Feb 28, 2015 · Completed: Mar 31, 2029
6 conditions3 sponsors2 locations
NCT02203643
Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.
PHASE2Active, not recruiting
477 participants
Started: Feb 28, 2015 · Completed: Mar 26, 2026
1 condition1 sponsor1 location
NCT02603679
Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases
PHASE2Active, not recruiting
181 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2031
2 conditions1 sponsor3 locations
NCT02318732
Evaluation of California's Armed and Prohibited Persons System
NAActive, not recruiting
20,000 participants
Started: Feb 28, 2015 · Completed: Jun 21, 2025
1 condition4 sponsors1 location
NCT02381353
Exparel Injection for Postoperative Orbital Pain
PHASE4Recruiting
88 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT02438631
Placental Passage and Disposition of Drugs: A Physiology-based Approach
N/ARecruiting
2,000 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2028
1 condition5 sponsors1 location
NCT02323399
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
PHASE4Recruiting
100 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2024
1 condition1 sponsor10 locations
NCT02339064
Infusion of Apomorphine: Long-term Safety Study
PHASE3Active, not recruiting
99 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition1 sponsor18 locations
NCT02240862
The CREST-2 Registry
N/ARecruiting
8,000 participants
Started: Feb 28, 2015 · Completed: Jan 31, 2026
1 condition6 sponsors1 location
NCT02065362
TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
PHASE1Active, not recruiting
14 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2033
1 condition4 sponsors1 location
NCT02375841
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
N/AActive, not recruiting
309 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2026
2 conditions2 sponsors8 locations
NCT02381301
Biomarkers and Cardiac CT
N/ARecruiting
5,000 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT04039945
Fr1da Early Diagnosis and Care of Type 1 Diabetes
N/ARecruiting
285,000 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT02870244
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
PHASE1Recruiting
18 participants
Started: Feb 28, 2015 · Completed: Sep 30, 2028
1 condition2 sponsors1 location
NCT02852538
Outcomes of a Skill-Based Program for Eating Disorders
NAEnrolling by invitation
200 participants
Started: Feb 28, 2015 · Completed: Jan 31, 2027
1 condition2 sponsors2 locations
NCT02294435
Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms
NAActive, not recruiting
250 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT02371135
Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
N/AActive, not recruiting
77 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2026
2 conditions3 sponsors1 location
NCT02369003
Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS
PHASE1Active, not recruiting
70 participants
Started: Feb 28, 2015 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT02387736
DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical & Cost Effectiveness of a 6 mo. Treatment
NAActive, not recruiting
240 participants
Started: Feb 28, 2015 · Completed: Mar 31, 2025
1 condition3 sponsors2 locations
NCT02340676
A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD
PHASE2Active, not recruiting
25 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02407808
Cannabinoids, Learning, and Memory
PHASE1Active, not recruiting
80 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT02370797
Node Negative, Invasive Breast Cancer Single Fraction IOERT
NAActive, not recruiting
100 participants
Started: Feb 28, 2015 · Completed: May 31, 2029
1 condition1 sponsor1 location
NCT02678182
Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial
PHASE2Active, not recruiting
494 participants
Started: Feb 28, 2015 · Completed: Jun 30, 2027
3 conditions5 sponsors1 location
NCT02884284
Prospective and Retrospective Breast Cancer Database
N/ARecruiting
10,000 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02297672
Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant
NAActive, not recruiting
75 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT02346747
A Trial of Vigil for Participants With Ovarian Cancer
PHASE2Active, not recruiting
92 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
2 conditions1 sponsor26 locations
NCT02365090
Binocular iPad Sub-Study
NAActive, not recruiting
96 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03022682
Inflammation, Diabetes, Ethnicity and Obesity Cohort
N/ARecruiting
350 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT02919930
Interface Selection for Adaptive Servo Ventilation
NARecruiting
15 participants
Started: Feb 28, 2015 · Completed: Jan 31, 2025
2 conditions1 sponsor1 location
NCT02157025
A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics
NARecruiting
20 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT02316379
Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration
PHASE1/PHASE2Recruiting
100 participants
Started: Feb 28, 2015 · Completed: Aug 24, 2031
1 condition1 sponsor1 location
NCT03531658
Singapore PREconception Study of Long-Term Maternal and Child Outcomes
N/AActive, not recruiting
1,054 participants
Started: Feb 27, 2015 · Completed: Dec 31, 2029
7 conditions3 sponsors1 location
NCT01209871
Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma
PHASE1Active, not recruiting
9 participants
Started: Feb 26, 2015 · Completed: Feb 20, 2026
1 condition2 sponsors1 location
NCT02122185
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2Active, not recruiting
110 participants
Started: Feb 25, 2015 · Completed: Feb 25, 2027
28 conditions1 sponsor10 locations
NCT02315196
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
PHASE2Active, not recruiting
62 participants
Started: Feb 25, 2015 · Completed: Jul 31, 2041
9 conditions3 sponsors1 location
NCT01896479
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
PHASE4Active, not recruiting
247 participants
Started: Feb 25, 2015 · Completed: Jan 31, 2035
1 condition1 sponsor49 locations
NCT02273375
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
PHASE3Active, not recruiting
1,415 participants
Started: Feb 24, 2015 · Completed: Jan 31, 2026
1 condition11 sponsors271 locations
NCT06193850
Protocol N. 2014 - Observational Study on the Quality of Life of Outpatients
N/ARecruiting
10,000 participants
Started: Feb 24, 2015 · Completed: Jan 31, 2045
3 conditions1 sponsor1 location
NCT02362503
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
PHASE3Active, not recruiting
371 participants
Started: Feb 23, 2015 · Completed: Sep 30, 2026
1 condition1 sponsor139 locations